Literature DB >> 1949141

Screening in vitro of natural products against blood forms of Trypanosoma cruzi.

E Chiari1, A B de Oliveira, D S Raslan, A A Mesquita, K G Tavares.   

Abstract

Transmission of Chagas disease by blood transfusion is a major health problem in Central and South America. The annual incidence of transfusion-transmitted Chagas disease in Brazil is about 20,000 cases. Crystal violet is the only trypanosomicidal agent available at present, but there are some restrictions on its use. In a search for possible new chemoprophylactic agents, several natural products of different structural types were tested in vitro against infective blood trypomastigotes of Trypanosoma cruzi. Four compounds had high activity at a concentration of 5 x 10(-4) M: the diarylpropanoids (3R)-claussequinone, (R)-4-methoxydalbergione and (S)-4,4'-dimethoxy-dalbergione, and 15-deoxygoyazensolide, a sesquiterpenelactone. Haemoculture and serology of mice inoculated with infected blood treated with these active compounds were negative after 3 and 6 months. The benzoquinone moiety seemed to be important for this activity since lapachol and related naphthoquinones are known to be trypanosomicidal. 15-Deoxygoyazensolide has previously been recognized as a schistosomicide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949141     DOI: 10.1016/0035-9203(91)90296-b

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  Lychnopholide in Poly(d,l-Lactide)-Block-Polyethylene Glycol Nanocapsules Cures Infection with a Drug-Resistant Trypanosoma cruzi Strain at Acute and Chronic Phases.

Authors:  Renata Tupinambá Branquinho; Carlos Geraldo Campos de Mello; Maykon Tavares Oliveira; Levi Eduardo Soares Reis; Paula Mello de Abreu Vieira; Dênia Antunes Saúde-Guimarães; Vanessa Carla Furtado Mosqueira; Marta de Lana
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

2.  Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis.

Authors:  E Chiari; A B Oliveira; M A Prado; R J Alves; L M Galvão; F G Araujo
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

3.  Methodological advances in drug discovery for Chagas disease.

Authors:  Juan M Bustamante; Rick L Tarleton
Journal:  Expert Opin Drug Discov       Date:  2011-06       Impact factor: 6.098

4.  Pep5, a Fragment of Cyclin D2, Shows Antiparasitic Effects in Different Stages of the Trypanosoma cruzi Life Cycle and Blocks Parasite Infectivity.

Authors:  Christiane Bezerra de Araujo; Loyze Paola de Lima; Simone Guedes Calderano; Flávia Silva Damasceno; Ariel M Silber; Maria Carolina Elias
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

5.  Sesquiterpene lactone in nanostructured parenteral dosage form is efficacious in experimental Chagas disease.

Authors:  Renata Tupinambá Branquinho; Vanessa Carla Furtado Mosqueira; Jaquelline Carla Valamiel de Oliveira-Silva; Marianne Rocha Simões-Silva; Dênia Antunes Saúde-Guimarães; Marta de Lana
Journal:  Antimicrob Agents Chemother       Date:  2014-01-21       Impact factor: 5.191

6.  Chemical Diversity and Biological Activity of African Propolis.

Authors:  Natalia Blicharska; Veronique Seidel
Journal:  Prog Chem Org Nat Prod       Date:  2019

7.  Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase.

Authors:  F S Buckner; C L Verlinde; A C La Flamme; W C Van Voorhis
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

8.  Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii.

Authors:  C Atzori; A Bruno; G Chichino; E Bombardelli; M Scaglia; M Ghione
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

9.  High-throughput screen of natural product libraries for hsp90 inhibitors.

Authors:  Jason Davenport; Maurie Balch; Lakshmi Galam; Antwan Girgis; Jessica Hall; Brian S J Blagg; Robert L Matts
Journal:  Biology (Basel)       Date:  2014-02-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.